4D Molecular Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -239.4% | -239.3% |
| FY2022 | — | -310.8% | -303.7% |
| FY2023 | — | -295.5% | -264.0% |
| FY2024 | — | -507,678.4% | -434,778.4% |
| FY2025 | — | -187.2% | -164.4% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -239.4% | -239.3% |
| FY2022 | — | -310.8% | -303.7% |
| FY2023 | — | -295.5% | -264.0% |
| FY2024 | — | -507,678.4% | -434,778.4% |
| FY2025 | — | -187.2% | -164.4% |